ACST | Acasti Pharma Inc.

Healthcare | Biotechnology | Canada | NASD

Index	-	P/E	-	EPS (ttm)	-0.41	Insider Own	-	Shs Outstand	44.61M	Perf Week	1.38%
Market Cap	23.91M	Forward P/E	-	EPS next Y	-0.46	Insider Trans	-	Shs Float	35.46M	Perf Month	19.96%
Income	-17.20M	PEG	-	EPS next Q	-0.14	Inst Own	0.08%	Short Float / Ratio	1.47% / 8.78	Perf Quarter	9.41%
Sales	-	P/S	-	EPS this Y	79.90%	Inst Trans	-	Short Interest	0.52M	Perf Half Y	28.27%
Book/sh	2.17	P/B	0.25	EPS next Y	-6.30%	ROA	-14.00%	Target Price	2.00	Perf Year	-45.69%
Cash/sh	0.70	P/C	0.77	EPS next 5Y	-	ROE	-16.80%	52W Range	0.34 - 1.05	Perf YTD	7.23%
Dividend	-	P/FCF	-	EPS past 5Y	49.50%	ROI	-	52W High	-48.84%	Beta	1.52
Dividend %	-	Quick Ratio	9.70	Sales past 5Y	-	Gross Margin	-	52W Low	58.00%	ATR	0.03
Employees	32	Current Ratio	9.70	Sales Q/Q	-	Oper. Margin	-	RSI (14)	61.65	Volatility	5.86% 5.54%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	-2.20%	Profit Margin	-	Rel Volume	1.02	Prev Close	0.53
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	59.15K	Price	0.54
Recom	1.00	SMA20	7.67%	SMA50	13.57%	SMA200	-5.48%	Volume	60,338	Change	0.43%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-01-20	Downgrade	Oppenheimer	Outperform → Perform
Jul-06-20	Upgrade	B. Riley FBR	Neutral → Buy	$2
Jan-13-20	Downgrade	B. Riley FBR	Buy → Neutral
Aug-29-19	Initiated	B. Riley FBR	Buy	$7.75
Jul-18-19	Initiated	Oppenheimer	Outperform	$7
Jun-26-19	Initiated	H.C. Wainwright	Buy	$6

May-17-23 09:00AM	Acasti to Participate in the Lytham Partners Spring 2023 Investor Conference (PR Newswire)
May-10-23 07:41AM	We're Hopeful That Acasti Pharma (NASDAQ:ACST) Will Use Its Cash Wisely (Simply Wall St.)
May-08-23 07:00AM	Acasti Successfully Submits Pivotal GTX-104 Phase 3 Safety Study Protocol with FDA and Implements Strategic Realignment Plan That Extends Projected Cash Runway Through Calendar Q2 2025 (PR Newswire)
Apr-04-23 08:01AM	Acasti to Proceed with Phase 3 Clinical Safety Study for GTX-104 Following FDA Feedback, and Upon Approval of the Full Study Protocol to be Submitted to the IND (PR Newswire)
08:00AM	Acasti Announces Appointment of Prashant Kohli as CEO (PR Newswire)
08:30AM	Loading…
Mar-30-23 08:30AM	Acasti Pharma Inc. Announces the Resignation of a Director (PR Newswire)
06:57AM	When Will Acasti Pharma Inc. (NASDAQ:ACST) Turn A Profit? (Simply Wall St.)
Mar-13-23 08:00AM	Acasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture Exchange (PR Newswire)
Mar-08-23 09:00AM	Acasti Pharma to Participate in Oppenheimer 33rd Annual Healthcare Conference (PR Newswire)
Mar-04-23 08:28AM	We're Hopeful That Acasti Pharma (CVE:ACST) Will Use Its Cash Wisely (Simply Wall St.)
Feb-28-23 01:00PM	Acasti Pharma Recognizes Rare Disease Day (PR Newswire)
09:40AM	Has Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year? (Zacks)
Feb-15-23 04:02PM	Acasti Pharma Inc. (NASDAQ:ACST) Q3 2023 Earnings Call Transcript (Insider Monkey)
Feb-14-23 07:00AM	Acasti Pharma Reports Third Quarter 2023 Operational Results (GlobeNewswire)
Feb-07-23 09:00AM	Acasti Pharma to Report Third Quarter 2023 Financial Results on Tuesday, February 14, 2023 (PR Newswire)
09:00AM	Loading…
Jan-25-23 09:00AM	Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule (GlobeNewswire)
Jan-24-23 04:15PM	Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31 (GlobeNewswire)
Jan-17-23 10:00AM	Sidoti's January Micro-Cap Conference (ACCESSWIRE) +5.63%
08:45AM	Acasti Pharma Discusses Positive Clinical Study Results for GTX-101 and GTX-102 and Upcoming Phase 3 Study for GTX-104 with The Stock Day Podcast (Newsfile)
Jan-13-23 09:00AM	Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18 (GlobeNewswire)
Jan-05-23 09:00AM	Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures (GlobeNewswire) +18.32%
Dec-29-22 06:02AM	Acasti Pharma Inc. (NASDAQ:ACST) Q2 2023 Earnings Call Transcript (Insider Monkey)
Dec-28-22 08:00AM	Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Companys Drug Candidate for the Treatment of Ataxia Telangiectasia (GlobeNewswire) +11.09%
Dec-22-22 08:00AM	Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Companys Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN) (GlobeNewswire) +11.99%
Nov-14-22 07:00AM	Acasti Pharma Reports Second Quarter 2023 Operational Results (GlobeNewswire)
Nov-09-22 04:15PM	Acasti Pharma to Present at Q4 Investor Summit (GlobeNewswire)
Nov-07-22 04:15PM	Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022 (GlobeNewswire) -6.01%
Sep-30-22 09:00AM	Acasti Announces Court Dismissal of Stockholder Litigation (GlobeNewswire)
Sep-29-22 09:00AM	Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders (GlobeNewswire)
Sep-21-22 08:45AM	Acasti Pharma Inc. Discusses Clinical Progress of Lead Assets and 2022 Catalysts with The Stock Day Podcast (Newsfile)
04:15PM	Loading…
Sep-14-22 04:15PM	Acasti Pharma to Participate in the Lytham Partners Fall 2022 Investor Conference (GlobeNewswire)
Sep-13-22 08:00AM	Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-102, the Companys Drug Candidate for the Treatment of Ataxia Telangiectasia (GlobeNewswire)
Sep-12-22 09:00AM	Acasti Pharma to Participate at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-11-22 01:00PM	Edited Transcript of ACST.V earnings conference call or presentation 11-Aug-22 5:00pm GMT (Thomson Reuters StreetEvents)
07:00AM	Acasti Pharma Reports First Quarter 2023 Operational Results (GlobeNewswire)
Aug-02-22 04:15PM	Acasti Pharma to Report First Quarter 2023 Financial Results on Thursday, August 11, 2022 (GlobeNewswire)
Jul-27-22 08:00AM	Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Companys Drug Candidate for the Treatment of Postherpetic Neuralgia (GlobeNewswire)
Jul-07-22 08:55AM	Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast (Newsfile)
Jun-22-22 06:10PM	Acasti Pharma Announces Annual Grants of Performance Stock Options (GlobeNewswire)
Jun-21-22 08:00AM	Acasti Pharma Reports Fiscal Year 2022 Operational Results (GlobeNewswire)
Jun-16-22 04:15PM	Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call (GlobeNewswire) -5.26%
Jun-14-22 08:00AM	Acasti Pharma Announces the Issuance of Additional Patents for GTX-104 and GTX-101 (GlobeNewswire)
May-23-22 04:15PM	Acasti Pharma Inc. Retains Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program (PR Newswire)
May-18-22 11:20AM	Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine (Benzinga)
07:30AM	Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints (GlobeNewswire)
May-16-22 01:30PM	Update: Acasti Pharma CEO to Present at Microcap Rodeos Spring into Action Best Ideas Virtual Conference on May 18th (ACCESSWIRE)
01:20PM	36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 (ACCESSWIRE)
May-12-22 08:00AM	Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th (ACCESSWIRE)
May-06-22 09:02AM	10 Biotech Penny Stocks Redditors Love (Insider Monkey)
Apr-25-22 08:30AM	Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th (GlobeNewswire)
Mar-25-22 07:30AM	Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors (GlobeNewswire)
Mar-22-22 07:30AM	Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan (GlobeNewswire)
Mar-09-22 08:30AM	Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th (GlobeNewswire)
Feb-28-22 08:30AM	Acasti Pharma Celebrates Rare Disease Day (GlobeNewswire)
Feb-23-22 09:50AM	New Strong Sell Stocks for February 23rd (Zacks)
Feb-22-22 09:09AM	Acasti Pharma Inc. CEO, Jan D'Alvise, Is Featured on The Stock Day Podcast (Newsfile) -6.78%
Feb-14-22 07:00AM	Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022 (GlobeNewswire) +7.02%
Feb-07-22 08:30AM	Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call (GlobeNewswire)
Jan-03-22 08:30AM	Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference (GlobeNewswire) +9.52%
Dec-23-21 10:49AM	BLITF Stock: 7 Thing to Know About Mobile Gaming Play i3 Interactive as Shares Rocket Today (InvestorPlace) -17.16%
Dec-22-21 03:40PM	ACST Stock Price Predictions: Why One Analyst Sees Acasti Rocketing to $6 (InvestorPlace) +52.25%
07:28AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Dec-21-21 04:57AM	Market Sentiment Around Loss-Making Acasti Pharma Inc. (CVE:ACST) (Simply Wall St.)
Dec-02-21 07:00AM	Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104 (GlobeNewswire)
Nov-24-21 08:30AM	Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd (GlobeNewswire) +6.72%
Nov-12-21 05:34PM	Acasti Pharma Announces Annual Stock Option Grants (GlobeNewswire)
Nov-11-21 08:30AM	Acasti Pharma To Present At The Q4 Investor Summit on November 16th (Newsfile)
Nov-10-21 07:00AM	Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022 (GlobeNewswire)
Nov-04-21 08:30AM	Acasti Pharma Schedules Second Quarter Fiscal 2022 Business Update Conference Call (GlobeNewswire)
Oct-07-21 10:15AM	Monteverde & Associates PC Filed A Class Action Lawsuit On Behalf Of Shareholders Of Acasti Pharma, Inc. In The Southern District Of New York (ACCESSWIRE)
Oct-06-21 08:30AM	Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan (GlobeNewswire)
Sep-27-21 08:30AM	Acasti Pharma Announces Initiation of Pharmacokinetic Bridging Study for GTX-104, the Companys Lead Drug Candidate for the Treatment of Subarachnoid Hemorrhage (GlobeNewswire)
Sep-22-21 08:30AM	Acasti Pharma Provides Update Following Acquisition of Grace Therapeutics and Regains Compliance with Nasdaq Listing Standards (GlobeNewswire)
Sep-14-21 08:30AM	Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21 (GlobeNewswire) -10.20%
Sep-08-21 08:30AM	Acasti Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (GlobeNewswire)
Aug-31-21 02:27PM	Why Shares of Acasti Pharma Slumped Tuesday (Motley Fool) -16.77%
Aug-27-21 08:40AM	Acasti Pharma Announces Successful Completion of its Merger with Grace Therapeutics, Inc., Voting Results of its Annual and Special Meeting of Shareholders and Reverse Stock Split (GlobeNewswire)
Aug-25-21 07:02AM	21 Stocks Moving in Wednesday's Pre-Market Session (Benzinga)
Aug-12-21 07:00AM	Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022 (GlobeNewswire)
Jul-29-21 08:30AM	Reminder: Acasti Pharma to Host Conference Call on August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics (GlobeNewswire)
Jul-23-21 08:30AM	Acasti Pharma Schedules Conference Call for August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics (GlobeNewswire)
Jul-07-21 09:00AM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, SHSP, ICBK, ACST; Shareholders are Encouraged to Contact the Firm (GlobeNewswire) -6.67%
Jul-06-21 11:02AM	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Acasti Pharma Inc. Merger (GlobeNewswire)
Jul-03-21 06:52PM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates ACST, CLDR, DISCA, GRA, TRMT, XEC; Shareholders are Encouraged to Contact the Firm (PR Newswire)
12:14AM	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Acasti Pharma, Inc. - ACST (PR Newswire)
Jun-24-21 03:22AM	Acasti Pharma Inc.'s (CVE:ACST) Shift From Loss To Profit (Simply Wall St.)
Jun-23-21 08:27AM	Wednesdays Pre-Market: Heres What You Need to Know Before the Market Opens (TipRanks) +10.44%
Jun-22-21 07:00AM	Acasti Pharma Provides Fiscal 2021 Year-End Business Update (GlobeNewswire) +10.20%
Jun-14-21 04:20PM	10 Best Biotech Penny Stocks to Buy Now (Insider Monkey)
May-17-21 07:00AM	Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance (GlobeNewswire)
May-13-21 06:05PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UFS, FOE, CHMA, ACST; Shareholders are Encouraged to Contact the Firm (PR Newswire)
May-12-21 05:31PM	ACASTI PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Acasti Pharma Inc. - ACST (Business Wire)
May-07-21 11:53AM	Acasti Pharma To Acquire Grace Therapeutics: Highlights (Benzinga) +16.49%
11:14AM	Acasti Pharma Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Acasti Pharma Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm ACST (Business Wire)
07:00AM	Acasti Announces Definitive Agreement to Acquire Grace Therapeutics, Inc. (GlobeNewswire)
Mar-08-21 05:30PM	Acasti Pharma Provides Update on Recent Financing Activities (GlobeNewswire)
Feb-09-21 06:55AM	Acasti Pharma Announces Results for Third Quarter of Fiscal 2021 (GlobeNewswire) +8.89%
Jan-27-21 06:55AM	Acasti Pharma Provides Update on Recent Financing Activities (GlobeNewswire) -7.33%
Dec-25-20 12:00PM	Acasti (ACST) Moves to Buy: Rationale Behind the Upgrade (Zacks)
Dec-23-20 03:24PM	Acasti Pharma Unaware of Any Material Change (GlobeNewswire) +72.00%

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACST | Acasti Pharma Inc.

Upgrade your FINVIZ experience